ArticleArthritis & rheumatology (Hoboken, N.J.)2021

Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients.

Julie J Paik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.